PB Fintech Board Approves INR 696 Cr Investment in Healthcare Arm

The investment, to be made through equity shares or compulsorily convertible preference shares, is subject to shareholder approval via postal ballot.

PB Fintech, the parent company of Policybazaar, has approved an investment of up to INR 696 Cr in its wholly-owned subsidiary, PB Healthcare Services. 

The investment, to be made through equity shares or compulsorily convertible preference shares, is subject to shareholder approval via postal ballot.

PB Healthcare Services, incorporated in January 2025, operates in the healthcare and allied services sector. 

Reportedly, the board of PB Fintech approved the investment in its meeting on March 11, 2025. The company stated in a regulatory filing that the funds will be used for "subscribing or purchasing its equity shares or Compulsory Convertible Preference Shares during the financial year 2025-26."

The investment is classified as a related-party transaction but will be executed at fair value, determined by a registered valuer. PB Fintech clarified that the transaction aligns with its strategic objectives, ensuring that the healthcare arm is financially strengthened to meet operating expenses, enhance brand awareness, and execute strategic initiatives.

Following the investment, PB Fintech will hold up to 33.63% of PB Healthcare on a fully diluted basis. The company also announced that external investors, including key managerial personnel, would participate in the investment.

Regulatory Approvals & Timeline

PB Fintech's board has also approved a notice seeking this approval, which includes participation from Chairman and CEO Yashish Dahiya, Executive Vice Chairman Alok Bansal, and other key stakeholders. 

The company said that PB Healthcare will secure all required regulatory approvals before proceeding with the transaction.

The investment is expected to be finalized within 90 days of approvals.